Anzeige
Mehr »
Dienstag, 16.12.2025 - Börsentäglich über 12.000 News
Lithium wird plötzlich knapp: 3% Weltproduktion aktuell weg
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14Z8X | ISIN: SE0007464862 | Ticker-Symbol: Q3I
Frankfurt
15.12.25 | 08:16
0,119 Euro
+1,71 % +0,002
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ADDVISE GROUP AB Chart 1 Jahr
5-Tage-Chart
ADDVISE GROUP AB 5-Tage-Chart

Aktuelle News zur ADDVISE GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiADDvise Group AB (publ) receives observation status206Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ). The rules of Nasdaq First North Growth Market state...
► Artikel lesen
ADDVISE GROUP Aktie jetzt für 0€ handeln
MiAMPLEX AB: Amplex publishes the offer document for the public cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)4
MiAmplex AB announces a cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)7
MiADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex105Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price...
► Artikel lesen
12.11.ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million131ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3...
► Artikel lesen
23.10.ADDvise Group AB (publ): Interim report 2025, January 1-September 30118Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive....
► Artikel lesen
17.07.ADDvise Group AB (publ): Interim report 2025, January 1-June 30147In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow...
► Artikel lesen
11.07.ADDVISE GROUP AB: ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm2
09.07.ADDVISE GROUP AB: Invitation to presentation of interim report April 1 - June 30, 20251
26.05.ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year1.576ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will...
► Artikel lesen
12.05.ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs151Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for...
► Artikel lesen
12.05.ADDvise Group AB (publ): Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025162ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved...
► Artikel lesen
09.05.ADDvise Group AB (publ): Interim report 2025, January 1-March 31164In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating...
► Artikel lesen
24.04.New equity right for trading, ADDvise Group AB234At the request of ADDvise Group AB, equity rights will be traded on First North Growth Market as from 25 April 2025. Security name: ADDvise Group AB TO 1 A Short...
► Artikel lesen
18.03.XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2025707Das Instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE EO -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025 The instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE...
► Artikel lesen
12.03.ADDvise Group AB (publ): Report from the extra ordinary general meeting in ADDvise Group AB (publ)355ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve...
► Artikel lesen
20.02.ADDvise Group AB (publ): Year-end report 2024, January 1-December 31238The fourth quarter of 2024 showed a turnaround in organic net revenue. In December alone, we are now back at positive organic growth of 4.8%. With new long-term financial targets, we are now taking...
► Artikel lesen
07.02.ADDvise Group AB (publ): ADDvise presents preliminary financial information for the fourth quarter of 2024 and updates long-term financial targets174The Board of Directors of ADDvise Group AB ("ADDvise" and the "Company") presents preliminary financial information for the fourth quarter of 2024 and has, in connection therewith, decided to update...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1